trial · primary record
EXE-346 Probiotic
HSIL, High Grade Squamous Intraepithelial Lesion
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 90 |
| Primary completion | 2028-05-31 |
| Primary endpoint | Proportion of participants with no disease present |
| Registry ID | NCT06949800 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:08.799Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06949800
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.